Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GETINGE (GNGBY : OTC)

• Company Description    Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. Number of Employees: 11,791

• Price / Volume Information    Yesterday's Closing Price: $22.66 Daily Weekly Monthly 20 Day Moving Average: 1,816 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 1.08 52 Week High: $22.85 52 Week Low: $14.84 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.71% 6.80% 12 Week 19.45% 8.50% Year To Date 38.30% 24.41%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL LINDHOLMSPIREN 7A - GOTHENBURG,V7 41756 SWE ph: 46-1-033-500-00 fax: 46-1-033-556-40 lars.mattsson@getinge.com http://www.getinge.com

• General Corporate Information    Officers Mattias Perjos - Chief Executive Officer and President Johan Malmquist - Chairman Carl Bennet - Vice Chairman Agneta Palmer - Chief Financial Officer Cecilia Daun Wennborg - Board member Peer Information GETINGE (CHCR) GETINGE (ESRX) GETINGE (MYDP) GETINGE (COR) GETINGE (GBCS) GETINGE (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 37427X104 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 10/17/25 Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: 1.08 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 1.25% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.28 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.25 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.03 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/17/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 20.05 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 14.19 Price / Sales: - EPS Growth vs. Year Ago Period: 9.52% vs. Previous Quarter: 15.00% Sales Growth vs. Year Ago Period: 9.75% vs. Previous Quarter: 9.37% ROE 06/30/25 - 10.46 03/31/25 - 10.24 12/31/24 - 9.84 ROA 06/30/25 - 5.38 03/31/25 - 5.40 12/31/24 - 5.36 Current Ratio 06/30/25 - 1.22 03/31/25 - 0.84 12/31/24 - 1.21 Quick Ratio 06/30/25 - 0.70 03/31/25 - 0.53 12/31/24 - 0.77 Operating Margin 06/30/25 - 9.15 03/31/25 - 9.19 12/31/24 - 9.18 Net Margin 06/30/25 - 4.24 03/31/25 - 4.15 12/31/24 - 4.71 Pre-Tax Margin 06/30/25 - 5.92 03/31/25 - 5.83 12/31/24 - 6.57 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - 2.73 03/31/25 - 2.71 12/31/24 - 2.61 Debt-to-Equity 06/30/25 - 0.27 03/31/25 - 0.05 12/31/24 - 0.21 Debt-to-Capital 06/30/25 - 21.42 03/31/25 - 4.65 12/31/24 - 17.35

Powered by Zacks Investment Research ©